Recent Blog Postings
- UPDATE: Gazyva® Shows Superiority Over Standard Therapy for People with Active Lupus Nephritis
- UPDATE: Investigational CAR-T Cell Therapy ADI-001 Receives FDA Fast Track Designation for Refractory Systemic Lupus Erythematosus with Extrarenal Involvement
- Black History Month 2025: Your Voice, Your Power